During the past decade, Burke Internal Medicine and Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 25 clinical trials were completed, i.e. on average, 156.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 15 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Burke Internal Medicine and Research" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "AstraZeneca" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Burke Internal Medicine and Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Cyclerion Therapeutics" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Burke Internal Medicine and Research" are "Type 2 Diabetes" (5 trials), "Cardiovascular Disease" (4 trials), "Type 2 Diabetes Mellitus" (4 trials), "Diabetes Mellitus, Type 2" (3 trials) and "Diabetic Gastroparesis" (2 trials). Many other conditions were trialed in "Burke Internal Medicine and Research" in a lesser frequency.

Most popular intervention types in "Burke Internal Medicine and Research" are "Drug" (28 trials), "Behavioral" (2 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Dapagliflozin" (2 trials), "Darusentan" (2 trials), "Diet" (2 trials) and "Exercise" (2 trials). Other intervention names were less common.

The vast majority of trials in "Burke Internal Medicine and Research" are 30 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Burke Internal Medicine and Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Burke Internal Medicine and Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Burke Internal Medicine and Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".